Post by Alira Health

▶️ Are you navigating how MFN pricing could impact US healthcare programs and how it may affect your company’s drug pricing, patient access, and launch strategies, particularly in Europe? This webinar replay provides a structured, fact-based examination of MFN pricing, combining US policy expertise with European pricing and access perspectives as well as the implication for Europe. Check out all the benefits of watching the recording below and start watching here: https://lnkd.in/dT6xdbWE Questions about the challenges raised by MFN pricing? Connect with Nerea Blanque Catalina for answers.